122 filings
Page 6 of 7
8-K
e8qx9htrghwjp 3nfuzc
12 May 05
Results of Operations and Financial Condition
12:00am
8-K
56h6xte yhxggj36bp0h
22 Mar 05
Scolr Pharma Reports Results for 2004
12:00am
8-K
q1vtjbxyqh09wwlj bil
11 Feb 05
Entry into a Material Definitive Agreement
12:00am
8-K
q6lr37 4s
25 Jan 05
Entry into a Material Definitive Agreement
12:00am
8-K
mqx9jiv
11 Jan 05
Entry into a Material Definitive Agreement
12:00am
8-K
wdj339g 053
18 Nov 04
Entry into a Material Definitive Agreement
12:00am
8-K
3n1 mjl0eg9v
12 Nov 04
Results of Operations and Financial Condition
12:00am
8-K
bj09jca
13 Aug 04
SCOLR PHARMA REPORTS SECOND QUARTER AND SIX-MONTH RESULTS – Prepares To Initiate Human Bio Trial for CDT®Ibuprofen
12:00am
8-K
0xjzv3
24 May 04
Other events
12:00am
8-K
t2kjj3l ls
26 Feb 04
Other events
12:00am
8-K
lcn 2evast
18 Feb 04
Financial statements and exhibits
12:00am
8-K
j452r41ha5may4q5xego
11 Feb 04
Financial statements and exhibits
12:00am
8-K
srnwh46bmb85lw
23 Jan 04
Acquisition or disposition of assets
12:00am
8-K
r4cysehv xdl15f0
12 Nov 03
Scolr, Inc. Announces Appointments to Its Board of Directors
12:00am
8-K
02ec9
14 Aug 03
Other events
12:00am
8-K
yhwldvhg1el9sb
8 Aug 03
SCOLR Expands Management Team to Accelerate Its Controlled Release Technology
12:00am
8-K
20prrb6p1hdg8kepj
27 Jun 03
Scolr, Inc. Completes $5.3 Million Financing of Six Percent Convertible Notes
12:00am
8-K
17qq558rwlx9eoaa xu
5 May 03
Other events
12:00am
8-K
c42oq6o7b731oxs
6 Nov 02
Other events
12:00am
8-K
5pv9j 2f5vrz
3 Oct 02
Other events
12:00am